Category: CBN, CBNC2, Major Cannabinoids in Cannabis

What is Cannabinol-C2? (CBN-C2)

Posted: September 21, 2020
Updated: December 25, 2023

What is Cannabinol C-2?

Cannabinol-C2 (CBN-C2) is a Sativa compound oxidized from CBN, one of the major cannabinoids found in the cannabis plant. CBN-C2 is a derivative of CBN. CBN is formed from the continuous exposure of tetrahydrocannabinolic acid (THCA) to heat in the presence of oxygen.

Researchers and scientists have been researching the cannabis plant since 1940, and have found multiple compounds in the plant. CBN-C2 was discovered in small quantities from aged cannabis plants.

The metamorphosis of cannabinolic acid is the neutralization of compounds from their precursors.

This could happen through the process of decarboxylation, or in some cases like CBN-C2, oxidation is what occurs. CBN-C2, unlike others, is formed through continuous degradation of the THCA compound.

The exposure of THCA to light, oxygen is the cause of CBN-C2. The downside of this formation is that it doesn’t happen unless required by scientists or through the carelessness of cultivators. If the cannabis plant is well preserved, the CBN-C2 compound is likely not to be formed.

Related: What is CBN?

The CBN compound is one useful compound with therapeutic benefits in the medical field. It is used as a sleeping aid, and thus there is a high level of research going on around the functions of the compound.

The CBN-C2 compound is expected to go through research once the go-ahead for research has been gotten following the debates happening around the legalization of marijuana and its use in the medical field by necessary actors like the FDA, United Nations, World Health Organization, etc.

How Does CBN-C2 Work?

CBN-C2 comes in little or no quantity in a fresh cannabis plant. Also, CBN being an illegal compound in most countries is blocking researchers from being able to learn more about this compound.

Related: CBN vs CBD Explained

The little to no information available about this compound hasn’t allowed researchers to understand exactly how it works and how it will react to the human body.

We know that CBN is a strong sleeping agent and more sedative than THC, but we cannot assume that CBN-C2 works the same way as its mother compound considering the difference in functions of the CBN from its mother compound, THC.

We don’t know how it works and can only hope researchers unlock its potentials in the nearest future.

Are There Benefits of CBN-C2?

We know that CBN has the therapeutic benefits of helping with insomnia and mild pain relief.

What researchers haven’t been able to pinpoint is the particular functions of the CBN-C2 compound and how its difference in chemical composition will affect or alter CBN’s therapeutic functions.

There are no tests or facts to prove or show the possible therapeutic benefits of the CBN-C2 compound. Nonetheless, we know that CBN has no psychoactive tendencies, meaning it can be used and no intoxicating effect will be observed

Interesting Facts About CBN-C2

CBN-C2 is not formulated from CBG or CBGA but the degradation of THCA.
It exists largely in aged cannabis plants.
CBN-C2, in most cases, is deliberately created in the lab by the exposure of marijuana to UV light in the presence of air.

References

Karniol IG, Shirakawa I, Takahashi RN, Knobel E, Musty RE (1975). “Effects of delta9-tetrahydrocannabinol and cannabinol in man”. Pharmacology. 13 (6): 502–12.

National Center for Biotechnology Information (2020). PubChem Compound Summary for CID 2543, Cannabinol.

Back to List of Cannabinoids

Search our website for more information on CBD:

Related Cannabinoids

DELTA-9-CIS-TETRAHYDROCANNABINOL (CIS-THC)

Cannabinol-C4 (CBN-C4)

What is Cannabinol-C2? (CBN-C2)

CANNABINOLIC ACID (CBNA)

What is Cannabidiorcol (CBN-C1)?

Commitment to Trusted Information on CBD

When it comes to understanding both the science and benefits of cannabidiol (CBD), it is extremely important that you can trust the source of your information. This is exactly why our team at New Phase Blends includes experts in the field of cannabinoid research and development, including frequent correspondence with certified medical professionals and PhDs in relevant fields via studies, research, and additional peer reviewed pieces of information. All information published is reviewed and checked for accuracy. We pride ourselves on staying up-to-date with the latest scientific research and clinical studies related to not only CBD, but also its effects on the human body.

Our website also includes an About Us page, where you can learn more about our team, mission, and commitment to providing accurate, reliable information about CBD. Users can access this from the header menu at the top of the screen. Additionally, all of our products are third-party lab tested for quality and purity, and we make the results of these tests easily accessible to our customers.

User Experience Strengthened Through The Use of AI Content

Some articles you read may contain content created by the use of AI tools. This content is always edited by a human. We fact check any AI content, and ensure the information produced is accurate, up to date, and relevant to the article it may be contained in. All content is verified against peer reviewed data on CBD written by PhD’s and respective experts in their field of medical science.

Our goal in using AI content is to increase the user experience by increasing content production, and quality. This results in more information becoming available to the reader more frequently.

About the Author - CBD Expert Dale Hewett

Dale Hewett

Dale Hewett is the owner and founder of New Phase Blends. He discovered his passion for CBD use after suffering from injuries sustained while on Active Duty in the US Army. His number one priority is introducing the same CBD products that he himself uses for relief to others who can benefit from them.

Dale holds a Master Degree of Science, and is the inventor of the popular, CBD-based sleep aid known as ‘Sleep.’ He’s given multiple lectures on CBD to institutions such as Cornell’s MBA student program, and Wharton’s School of Business.